ELAPRASE 2 mg/ml, solution à diluer pour perfusion — 1 flacon(s) en verre de 3 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930236536 -
CIP7
3023653 -
CIS
63288174 -
Registration number
EU/1/06/365
What the source publishes
- Holder
- TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- Active ingredients
- IDURSULFASE
- Form
- solution à diluer pour perfusion
- Package
- 1 flacon(s) en verre de 3 ml
- Routes
- intraveineuse
- Administrative status
- authorised
- Supply regime
- prescription hospitalière ; liste I ; la première administration doit être effectuée en milieu hospitalier
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2007-01-08
- Prescription
- Prescription or restricted
Names this record is found by
- ELAPRASE 2 mg/ml, solution à diluer pour perfusion — 1 flacon(s) en verre de 3 ml
- ELAPRASE 2 mg/ml, solution à diluer pour perfusion
- IDURSULFASE
Complete source data
{
"cis": "63288174",
"cip7": "3023653",
"form": "solution à diluer pour perfusion",
"name": "ELAPRASE 2 mg/ml, solution à diluer pour perfusion — 1 flacon(s) en verre de 3 ml",
"cip13": "3400930236536",
"holder": "TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)",
"routes": [
"intraveineuse"
],
"holders": [
"TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "2562.05",
"authorisedOn": "2007-01-08",
"compositions": [
{
"name": "IDURSULFASE",
"nature": "SA",
"strength": "2 mg",
"linkageNumber": "1",
"substanceCode": "95311",
"dosageReference": "1 ml",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription hospitalière ; liste I ; la première administration doit être effectuée en milieu hospitalier",
"dispensingFee": "1.02",
"medicinePrice": "2561.03",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ELAPRASE 2 mg/ml, solution à diluer pour perfusion",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) en verre de 3 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100 %"
],
"marketingDeclaredOn": "2022-05-02",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"IDURSULFASE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription hospitalière",
"liste I",
"la première administration doit être effectuée en milieu hospitalier"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/06/365",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930236536"